BATF3 and neoplasm: Analysis of these tumours in the setting of the ovalbumin-OT-I, a model antigen expression system, confirmed an increase in antigen-specific CD8+ T-cells in versikine-expressing tumours providing confirmation of the capacity of Batf3-expressing dendritic cells to drive anti-tumour immunity [141].